RBC Bioscience (ROCO:6848) Pre-Tax Income : NT$7.9 Mil (TTM As of Dec. 2023)

RBC Bioscience Pre-Tax Income Chart

RBC Bioscience Semi-Annual Data
	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Pre-Tax Income	Get a 7-Day Free Trial					5.58	10.84	-5.93	2.85	5.02

Competitive Comparison of RBC Bioscience's Pre-Tax Income

For the Biotechnology subindustry, RBC Bioscience's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

RBC Bioscience's Pre-Tax Income Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, RBC Bioscience's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where RBC Bioscience's Pre-Tax Income falls into.

RBC Bioscience Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

RBC Bioscience's Pretax Income for the fiscal year that ended in Dec. 2023 is calculated as

RBC Bioscience's Pretax Income for the quarter that ended in Dec. 2023 is calculated as

Pre-Tax Income for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was NT$7.9 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

RBC Bioscience  (ROCO:6848) Pre-Tax Income Explanation

RBC Bioscience's Pretax Margin for the quarter that ended in Dec. 2023 is calculated as

During the past 7 years, RBC Bioscience's highest Pretax Margin was 30.83%. The lowest was 2.83%. And the median was 12.36%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

RBC Bioscience Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of RBC Bioscience's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.

RBC Bioscience (ROCO:6848) Business Description